Nobias Therapeutics
Nobias Therapeutics develops small molecule therapeutics targeting genetically-defined rare diseases, utilizing extensive genomic and health datasets in collaboration with pediatric academic medical centers. The company focuses on accelerating drug discovery for pediatric indications, with plans to expand into adult and non-rare disease markets.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$21.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Nobias Therapeutics develops small molecule therapeutics targeting genetically-defined rare diseases, utilizing extensive genomic and health datasets in collaboration with pediatric academic medical centers. The company focuses on accelerating drug discovery for pediatric indications, with plans to expand into adult and non-rare disease markets.